NHL, ADULT

Clinical trials for NHL, ADULT explained in plain language.

Never miss a new study

Get alerted when new NHL, ADULT trials appear

Sign up with your email to follow new studies for NHL, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 'Living Drug' trial offers hope for lymphoma patients out of options

Disease control Recruiting now

This is a first-in-human study testing the safety and early effectiveness of a new cell therapy called SynKIR-310. It is for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments, including other CAR-T therapies. The main goa…

Matched conditions: NHL, ADULT

Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control

Last updated Mar 12, 2026 13:52 UTC

NHL, ADULT

Get alerted when new NHL, ADULT trials appear

New 'Living Drug' trial offers hope for lymphoma patients out of options